Dexcom stock price closed at $123.95, snapping a three-day losing streak. This rebound coincides with renewed optimism over international market expansion in CGM adoption. Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive. Cardinal Health, Inc. (CAH) : Free Stock Analysis Report Dexcom stock price near $124.20 aligns with a rising trend in digital health adoption, which market participants view as a multi-year growth catalyst.